Silence Therapeutics reported $-12.46M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AstraZeneca USD 4.66B 1.5B Sep/2026
Autolus Therapeutics Ltd USD -59.51M 12.95M Mar/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Novartis USD 5.14B 392M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Silence Therapeutics USD -12.46M 13.78M Dec/2025